Publication: Cartilage restoration in haemophilia: advanced therapies
Loading...
Full text at PDC
Publication Date
2012-09
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley Blackwell
Citations
Exportar
Abstract
Current treatment of joint cartilage lesions is based either on conventional techniques (bone marrow stimulation, osteochondral autograft or allograft transplantation) or on newly developed techniques (chondrocyte implantation and those based on cell therapy that use bioreactors, growth factors, mesenchymal stem cells [MSCs] and genetically modified cells). The aim of this article is to review the therapeutic strategies above mentioned and to determine whether the chondral damage seen in haemophilia could benefit from any of them. The different conventional techniques have shown similar results whereas autologous chondrocyte implantation, which is in common use at the present time, has not been shown to produce any conclusive results or to lead to the formation of hyaline cartilage. MSCs hold promise for the repair of joint cartilage given their differentiation capacity and the therapeutic effect. The use of bioreactors and growth factors, which stimulate cartilage formation, may optimize such strategies in the
context of reimplantation of chondrocytes, differentiated
MSCs and cartilage progenitor cells. The aim of cell therapy is restoration of function through the repair of damaged tissue or the stimulation of growth factor synthesis. Implantation of autologous chondrocytes or MSCs was up to now able to address only highly localized chondral lesions. Adequate control of the differentiation process as well as the use of growth factors and appropriate bioreactors could transform cell-based therapies into a more efficient and longer term treatment even for patients with haemophilia. Nevertheless, raising false expectations in these patients should be avoided. There are a number of approaches to cartilage restoration in haemophilic arthropathy, which are currently being explored for other joint related degenerative disorders. If it can be proven to be effective for the disorders in which clinical trials are ongoing and costs could be limited, it might be an useful palliative approach to haemophilic arthropathy. However, we still have a long way to go for use in haemophilic arthropathy.
Description
UCM subjects
Unesco subjects
Keywords
Citation
1 Farr J, Cole B, Dhawan A et al. Clinical
cartilage restoration: evolution and overview.
Clin Orthop Relat Res 2011; 469:2696–705.
2 Theodoropoulos JS, Amritha DeCroos JN,
Park SS et al. Integration of tissue-engineered
cartilage with host cartilage: an
in vitro model. Clin Orthop Relat Res 2011;469: 2785–95.
3 CurlWW,KromeJ,GordonESet al.Cartilage
injuries:areviewof31,516kneearthroscopies.Arthroscopy 1997; 13: 456–60.
4 Lexer E. The use of free osteoplasty together
with trials on arthrodesis and joint transplantation.
Archiv fur klin Chirurgie. 1908;86:939–954. Clin Orthop Relat Res 2008; 466: 1771–6.
5 Pridie K. A method of resurfacing osteoarthritic
knee joints. J Bone Joint Surg Am 1959; 41: 618–9.
6 Ficat RP, Ficat C, Gedeon P et al. Spongialization:
a new treatment for diseased patella. Clin Orthop Relat Res 1979; 144: 74–83.
7 Gross AE, Silverstein EA, Falk J et al. The
allotransplantation of partial joints in the
treatment of osteoarthritis of the knee. Clin Orthop Relat Res 1975; 108: 7–14.
8 Gross AE, Langer F, Houpt J et al. Allotransplantation
of partial joints in the treatment of osteoarthritis of the knee. Transplant Proc 1976; 8: 129–32.
9 Peterson L, Menche D, Grande D et al. Chondrocyte transplantation – an experimental model in the rabbit. Trans Orthop Res Soc 1984; 9: 218.
10 Vasiliadis HS, Wasiak J. Autologous chondrocyte
implantation for full thickness articular cartilage defects of the knee. Cochrane Database Syst Rev 2010; 10:
CD003323.
11 Rodriguez-Merchan EC. The treatment of cartilage defects in the knee joint: microfracture vs. mosaicplasty vs ACI. Am J Orthop 2012; 41: 236–9.
12 Liras A. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Transl Med 2010; 8: 131.
13 Patel AN, Genovese J. Potential clinical applications of adult human mesenchymal stem cell (Prochymal�) therapy. Stem Cells Cloning: Adv Appl 2011; 4: 61–72.
14 Khan WS, Johnson DS, Hardingham TE. The potential of stem cells in the treatment of knee cartilage defects. Knee 2010; 17:369–74.
15 Kamarul T, Selvaratnam L, Masjuddin T et al. Autologous chondrocyte transplantation in the repair of full-thickness y col. Autologous chondrocytetransplantation in the repair of full-thickness focal cartilage damage in rabbits. J Orthop Surg (Hong Kong) 2008; 16: 230–6.
16 Ando K, Imai S, Isoya E et al. Effect of dynamic compressive loading and its combination with a growth factor on the chondrocytic phenotype of 3-dimensional
scaffold-embedded chondrocytes. Acta Orthop 2009; 80: 724–33.
17 Maher SA, Mauck RL, Rackwitz L et al. A nanofibrous cell-seeded hydrogel promotes integration in a cartilage gap model. J Tissue Eng Regen Med 2010; 4: 25–9.
18 Pomahac B, Zuhaili B, Kudsi Y et al. Use of a smooth, resorbable template for delivery of cultured pellets of autologous chondrocytes to articular cartilage defects-preliminary report. Eplasty 2009; 9: e35.
19 ChondroCelect: EPAR product information. Available at http://www.ema.europa.eu/humandocs/Humans/EPAR/chondrocelect/chondrocelect.htm. Accessed April 2012.
20 RCT of ChondroCelect� (in an ACI procedure) vs microfracture in the repair of cartilage defects of the knee (TIGACT01). Available at http://clinicaltrials.gov/ct2/show/NCT00414700?term=NCT00414700 &rank=1. Accessed April 2012.
21 Wayne JS, McDowell CL, Shields KJ et al. In vivo response of polylactic acid-alginate scaffolds and bone marrowderived cells for cartilage tissue engineering. Tissue Eng 2005; 11: 953–63.
22 Campbell JJ, Lee DA, Bader DL. Dynamic compressive strain influences chondrogenic gene expression in human mesenchymal stem cells. Biorheology 2006; 43: 455–70.
23 Kisiday JD, Kopesky PW, Evans CH et al. Evaluation of adult equine bone marrowand adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008; 26: 322–31.
24 Meinel L, Hofmann S, Karageorgiou V et al. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng 2004; 88: 379–91.
25 Roberts JJ, Nicodemus GD, Greenwald EC et al. Degradation improves tissue formation in (un)loaded chondrocyte-laden hydrogels. Clin Orthop Relat Res 2011; 469: 2725–34.
26 Schumann D, Kujat R, Nerlich M et al. echanobiological conditioning of stem cells for cartilage tissue engineering. Biomed Mater Eng 2006; 16: S37–52.
27 Almqvist KF, Dhollander AA, Verdonk PC et al. Treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes. Am J Sports Med 2009; 37: 1920–9.
28 Comparison of BioCart�II with microfracture for treatment of cartilage defects of the femoral condyle. Available at http://clinicaltrials.gov/ct2/show/NCT00729716?term=
NCT00729716&rank=1. Accessed April 2012.
29 Confirmatory study of NeoCart in knee cartilage repair. Available at http://clinical trials.gov/ct2/show/NCT01066702?term= NCT01066702&rank=1. Accessed April 2012.
30 Instruct for repair of knee cartilage defects. Available at http://clinicaltrials.gov/ct2/ show/NCT01041885?term=cartilage+and+repair&rank=4. Accessed April 2012.
31 Ateshian GA, Hung CT. Patellofemoral joint biomechanics and tissue engineering. Clin Orthop Relat Res 2005; 436: 81–90. 32 Charlebois M, McKee MD, Buschmann MD. Nonlinear tensile properties of bovine articular cartilage and their variation with age and
depth. J Biomech Eng 2004; 126: 129–37.
33 Morrison EH, Ferguson MW, Bayliss MT et al. The development of articular cartilage: I. The spatial and temporal patterns of collagen types. J Anat 1996; 189: 9–22.
34 Williamson AK, Chen AC, Sah RL. Compressive properties and function–composition relationships of developing bovine articular cartilage. J Orthop Res 2001; 19:
1113–21.
35 Detterline AJ, Goldberg S, Bach BR Jr et al. Treatment options for articular cartilage defects of the knee. Orthop Nurs 2005; 24: 361–6
36 Kleemann RU, Schell H, Thompson M et al. Mechanical behavior of articular cartilage after osteochondral autograft transfer in an ovine model. Am J Sports Med 2007; 35:555–63.
37 Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res 2001; 391: S362–9.
38 Knutsen G, Engebretsen L, Ludvigsen TC et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004; 86: 455–64.
39 Micheli LJ, Browne JE, Erggelet C et al. Autologous chondrocyte implantation of the knee: multicenter experience and minimum 3-year follow-up. Clin J Sport Med 2001; 11: 223–8.
40 Micheli L, Curtis C, Shervin N. Articular cartilage repair in the adolescent athlete: is autologous chondrocyte implantation the answer? Clin J Sport Med 2006; 16: 465–70.
41 Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8: 301–16.
42 Getgood A, Brooks R, Fortier L et al. Articular cartilage tissue engineering: today�s research, tomorrow�s practice? J Bone Joint Surg Br 2009; 91: 565–76.
43 Assessment of outcome of meniscus repair with or without platelet rich plasma. Available at http://clinicaltrials.gov/ct2/show/NC
T00961597?term=NCT00961597&rank=1. Accessed April 2012.
44 Study of AS902330 (rhFGF-18) administered intra-articularly in patients with knee primary osteoarthritis who are candidates for total knee replacement. Available at http://clinicaltrials.gov/ct2/show/NCT00911469?erm=NCT00911469&rank=1. AccessedApril 2012.
45 A multicenter study of rhFGF 18 in patients with knee osteoarthritis not requiring surgery. Available at. http://clinicaltrials.gov/ct2/show/NCT01033994?term=NCT01033994&rank=1. Accessed April 2012.
46 Fortier LA, Barker JU, Strauss EJ et al. The role of growth factors in cartilage repair. Clin Orthop Relat Res 2011; 469: 2706–15.
47 Tan AR, Dong EY, Andry JP et al. Coculture of engineered cartilage with primary chondrocytes induces expedited growth. Clin Orthop Relat Res 2011; 469: 2735–43.
48 Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006; 97: 33–44.
49 Dhinsa BS, Adesida AB. Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Curr Stem Cell Res Ther 2012; 7: 143–8.
50 Mohal JS, Tailor HD, Khan WS. Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications. Curr Stem Cell Res Ther 2012; 7:103–9.
51 Caplan AI. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 2005; 11: 1198–211.
52 Cui L, Wu Y, Cen L et al. Repair of articular cartilage defect in non-weight bearing areas using adipose derived stem cells loaded polyglycolic acid mesh. Biomaterials 2009; 30: 2683–93.
53 Pei M, He F, Boyce BM et al. Repair of fullthickness
femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs. Osteoarthr Cartil 2009; 17:714–22.
54 Ruiz-Ibán MA, DÃaz-Heredia J, GarcÃa-Gómez I et al. The effect of the addition of adipose-derived mesenchymal stem cells to a meniscal repair in the avascular zone: An
experimental study in rabbits. Arthroscopy 2011; 27: 1688–96.
55 Mesenchymal stem cells in a clinical trial to heal articular cartilage defects. Available at http://clinicaltrials.gov/ct2/show/NCT00885729?term=NCT00885729&rank=1. Accessed April 2012.
56 Study to compare the efficacy and safety of Cartistem� and microfracture in patients with knee articular cartilage injury or defect. Available at http://clinicaltrials.gov/ct2/show/NCT01041001?term=NCT01041001&rank=1. Accessed April 2012.
57 The use of autologous bone marrow mesenchymal stem cells in the treatment of articular cartilage defects. Available at http://clinicaltrials.gov/ct2/show/NCT00891
501?term=NCT00891501&rank=1. Accessed April 2012.
58 Autologous transplantation of mesenchymal stem cells (MSCs) and scaffold in fullthickness articular cartilage. Available at http://clinicaltrials.gov/ct2/show/NCT00850
187?term=NCT00850187&rank=1. Accessed April 2012.
59 Kobayashi S, Takebe T, Inui M et al. Reconstruction of human elastic cartilage by a CD44 + CD90 + stem cell in the ear perichondrium. Proc Natl Acad Sci USA 2011; 108: 14479–84.
60 Rodriguez-Merchan EC. Cartilage damage in the haemophilic joints: pathophysiology,diagnosis and management. Blood Coagul Fibrinolysis 2012; 23: 179–83.
61 Soreff J. Joint debridement in the treatment of advanced hemophilic knee arthropathy. Clin Orthop Relat Res 1984; 191: 179–84.
62 Rodriguez-Merchan EC, Magallon M, Galindo E. Joint debridement for haemophilic arthropathy of the knee. Int Orthop 1994; 18: 135–8.
63 Rodriguez-Merchan EC. Ankle surgery in haemophilia with special emphasis on arthroscopic debridement. Haemophilia 2008; 14: 913–9.
64 Rodriguez-Merchan EC. Aspects of current management: orthopaedic surgery in haemophilia. Haemophilia 2012; 18: 8–16